Lineage Cell Therapeutics furnishes corporate investor presentation dated Jan 23, 2023

Lineage Cell Therapeutics, Inc.

Presentation covers Lineage's product candidates and recent business developments.
Filed under Regulation FD; presentation furnished, not filed.
No specific financial or operational updates disclosed in available text.

item 7.01 item 9.01

Lineage Cell Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-002127

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.